ONYX PHARMACEUTICALS INC·4

Dec 3, 1:33 PM ET

JEW JEANNE Y 4

4 · ONYX PHARMACEUTICALS INC · Filed Dec 3, 2003

Insider Transaction Report

Form 4
Period: 2003-12-02
JEW JEANNE Y
VP, Corporate & Commercial Dev
Transactions
  • Exercise/Conversion

    Common Stock

    2003-12-02$6.46/sh+15,000$96,90015,000 total
  • Sale

    Common Stock

    2003-12-02$29.80/sh400$11,92014,600 total
  • Sale

    Common Stock

    2003-12-02$29.79/sh1,500$44,68513,100 total
  • Sale

    Common Stock

    2003-12-02$29.78/sh300$8,93412,800 total
  • Sale

    Common Stock

    2003-12-02$29.77/sh300$8,93112,500 total
  • Sale

    Common Stock

    2003-12-02$29.76/sh100$2,97612,400 total
  • Sale

    Common Stock

    2003-12-02$29.74/sh700$20,81811,700 total
  • Sale

    Common Stock

    2003-12-02$29.73/sh100$2,97311,600 total
  • Sale

    Common Stock

    2003-12-02$29.72/sh500$14,86011,100 total
  • Sale

    Common Stock

    2003-12-02$29.70/sh1,400$41,5809,700 total
  • Sale

    Common Stock

    2003-12-02$29.64/sh100$2,9649,600 total
  • Sale

    Common Stock

    2003-12-02$29.60/sh100$2,9609,500 total
  • Sale

    Common Stock

    2003-12-02$29.58/sh100$2,9589,400 total
  • Sale

    Common Stock

    2003-12-02$29.55/sh600$17,7308,800 total
  • Sale

    Common Stock

    2003-12-02$29.50/sh200$5,9018,600 total
  • Sale

    Common Stock

    2003-12-02$29.51/sh700$20,6577,900 total
  • Sale

    Common Stock

    2003-12-02$29.52/sh500$14,7607,400 total
  • Sale

    Common Stock

    2003-12-02$29.50/sh675$19,9136,725 total
  • Sale

    Common Stock

    2003-12-02$29.46/sh400$11,7846,325 total
  • Sale

    Common Stock

    2003-12-02$29.43/sh100$2,9436,225 total
  • Sale

    Common Stock

    2003-12-02$29.42/sh5,825$171,372400 total
  • Sale

    Common Stock

    2003-12-02$29.41/sh100$2,941300 total
  • Sale

    Common Stock

    2003-12-02$29.40/sh200$5,880100 total
  • Sale

    Common Stock

    2003-12-02$29.32/sh100$2,9320 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1]
    2003-12-0215,00085,000 total
    Exercise: $6.46From: 2003-11-25Exp: 2013-11-25Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable as to 25% on the first anniversary of the date of grant and 1/48th monthly thereafter.
Signature
/s/ Marilyn E. Wortzman, Attorney-in-fact|2003-12-02

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION